This page lists the SEC filings reported by GrowthWorks Capital Ltd..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2015-02-13 | GrowthWorks Capital Ltd. | Celator Pharmaceuticals Inc | 1,378,445 | - | EDGAR |
| SC 13G/A | 2014-02-13 | GrowthWorks Capital Ltd. | TEKMIRA PHARMACEUTICALS Corp | 0 | - | EDGAR |
| SC 13G | 2014-02-13 | GrowthWorks Capital Ltd. | Celator Pharmaceuticals Inc | 1,605,830 | - | EDGAR |
| SC 13G/A | 2013-02-12 | GrowthWorks Capital Ltd. | TEKMIRA PHARMACEUTICALS Corp | 782,050 | - | EDGAR |
| SC 13G/A | 2012-11-28 | GrowthWorks Capital Ltd. | TEKMIRA PHARMACEUTICALS Corp | 1,175,793 | - | EDGAR |
| SC 13G/A | 2011-06-24 | GrowthWorks Capital Ltd. | TEKMIRA PHARMACEUTICALS Corp | 2 | - | EDGAR |
| SC 13D/A | 2011-02-14 | GrowthWorks Capital Ltd. | ONCOGENEX PHARMACEUTICALS, INC. | 380,149 | 3.9% | EDGAR |
| SC 13G | 2011-02-14 | GrowthWorks Capital Ltd. | TEKMIRA PHARMACEUTICALS CORP | 1,306,467 | - | EDGAR |
| SC 13D/A | 2009-08-26 | GrowthWorks Capital Ltd. | ONCOGENEX PHARMACEUTICALS, INC. | 434,104 | 7.2% | EDGAR |
| SC 13D/A | 2009-02-17 | GrowthWorks Capital Ltd. | ONCOGENEX PHARMACEUTICALS, INC. | 525,844 | 9.5% | EDGAR |
| SC 13D/A | 2008-12-23 | GrowthWorks Capital Ltd. | ONCOGENEX PHARMACEUTICALS, INC. | 525,844 | 9.5% | EDGAR |
| SC 13D | 2008-09-02 | GrowthWorks Capital Ltd. | ONCOGENEX PHARMACEUTICALS, INC. | 363,477 | 6.6% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.